Get the Stockscreener App
7.58
1.56%
-0.12
After Hours:
7.84
0.26
+3.43%
Senseonics Holdings Inc stock is traded at $7.58, with a volume of 457.39K.
It is down -1.56% in the last 24 hours and up +6.61% over the past month.
Senseonics Holdings, Inc., a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days. The company has a research and development license agreement with TypeZero Technologies, Inc. and Roche Diabetes Care, Inc. to develop a closed loop diabetes management system that allow users to automatically maintain tight glucose control while avoiding hypoglycemia. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
See More
Previous Close:
$7.70
Open:
$7.7
24h Volume:
457.39K
Relative Volume:
0.99
Market Cap:
$309.71M
Revenue:
$22.39M
Net Income/Loss:
$-60.39M
P/E Ratio:
-67.80
EPS:
-0.1118
Net Cash Flow:
$-70.51M
1W Performance:
+9.70%
1M Performance:
+6.61%
6M Performance:
-19.94%
1Y Performance:
-67.61%
1-Day Range:
$7.36
$7.70
1-Week Range:
$6.78
$8.75
52-Week Range:
$5.25
$28.00
Senseonics Holdings Inc Stock (SENS) Company Profile
Name
Senseonics Holdings Inc
Sector
Industry
Phone
301-515-7260
Address
20451 Seneca Meadows Parkway, Germantown, MD
Compare SENS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SENS
Senseonics Holdings Inc
|
7.58 | 314.61M | 22.39M | -60.39M | -70.51M | -0.1118 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Senseonics Holdings Inc Stock (SENS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-21-25 | Resumed | Stifel | Hold |
| Aug-27-25 | Initiated | Barclays | Overweight |
| Jul-15-25 | Initiated | TD Cowen | Buy |
| Jun-02-25 | Resumed | H.C. Wainwright | Buy |
| Apr-10-25 | Initiated | Mizuho | Outperform |
| Jul-19-23 | Initiated | Jefferies | Underperform |
| Aug-19-21 | Initiated | H.C. Wainwright | Buy |
| Apr-01-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Mar-05-21 | Downgrade | Raymond James | Mkt Perform → Underperform |
| Jan-21-21 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-20-21 | Downgrade | Craig Hallum | Hold → Sell |
| Aug-11-20 | Upgrade | BTIG Research | Neutral → Buy |
| Aug-11-20 | Upgrade | Craig Hallum | Sell → Hold |
| Mar-13-20 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-20 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-13-19 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-13-19 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-23-19 | Initiated | Stifel | Buy |
| Jul-05-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-29-19 | Initiated | Piper Jaffray | Neutral |
| Aug-24-18 | Initiated | Dougherty & Company | Buy |
View All
Senseonics Holdings Inc Stock (SENS) Latest News
Targets Report: Is SRG.PRA stock a good pick for beginnersQuarterly Portfolio Summary & Long-Term Capital Growth Strategies - baoquankhu1.vn
All You Need to Know About Senseonics (SENS) Rating Upgrade to Buy - Yahoo Finance
Continuous Glucose Monitoring Market to Grow at a Robust CAGR - openPR.com
Why Analysts See Senseonics Holdings (SENS) Story Shifting After Target Cut And Stock Split - Yahoo Finance
Senseonics (SENS) Moves 5.3% Higher: Will This Strength Last? - Yahoo Finance
Will Senseonics Holdings Inc outperform its industry peersQuarterly Market Review & AI Forecasted Stock Moves - baoquankhu1.vn
SENS Stock Up as Eversense 365 CGM Wins European CE Mark Approval - Yahoo Finance
Senseonics wins CE mark for one-year CGM - Yahoo Finance
Senseonics receives CE mark for one-year CGM system in Europe By Investing.com - Investing.com South Africa
Senseonics receives CE mark for one-year CGM system in Europe - Investing.com Nigeria
Senseonics (SENS) Gains CE Mark Approval for Eversense 365 CGM S - GuruFocus
Senseonics Receives European Approval for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor - The Manila Times
A year between CGM sensor changes: diabetes implant wins EU approval - stocktitan.net
Does Senseonics Holdings Inc. meet Warren Buffett’s criteriaJuly 2025 Final Week & Consistent Profit Trade Alerts - Mfd.ru
Senseonics Holdings, Inc. to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - The Manila Times
Quarterly Trades: Will Senseonics Holdings Inc outperform tech stocksTrade Signal Summary & Fast Gaining Stock Reports - baoquankhu1.vn
Senseonics Holdings, Inc. (NYSE:SENS) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Senseonics (NYSE:SENS) Stock Price Up 3.9%Time to Buy? - MarketBeat
What chart patterns are forming on Senseonics Holdings Inc.Earnings Beat & Verified Chart Pattern Signals - bollywoodhelpline.com
Is Senseonics Holdings Inc. stock a defensive play in 2025Options Play & Community Consensus Trade Signals - bollywoodhelpline.com
How The Evolving Story For Senseonics Holdings (SENS) Is Reshaping Analyst Valuation Targets - Yahoo Finance
Senseonics Holdings, Inc.'s (NASDAQ:SENS) Shares Climb 27% But Its Business Is Yet to Catch Up - 富途资讯
Aug Volume: Is Senseonics Holdings Inc in a bullish channelJuly 2025 Outlook & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Senseonics Holdings, Inc.'s (NASDAQ:SENS) Share Price Could Signal Some Risk - simplywall.st
Senseonics reports 71% revenue growth in Q4, guides higher for 2026 - Investing.com Nigeria
Senseonics reports 71% revenue growth in Q4, guides higher for 2026 By Investing.com - Investing.com South Africa
Senseonics (SENS) Reports Robust Q4 2025 Revenue Growth - GuruFocus
SENS Anticipates Strong Growth in 2026 with Key Developments - GuruFocus
Senseonics Reports Record 2025 Revenue and Growth Milestones - TipRanks
Senseonics (SENS) Projects Strong Revenue Growth for 2026 - GuruFocus
Senseonics Announces Preliminary Unaudited Revenue for Fourth Quarter 2025 and Provides Business Update - The Manila Times
Diabetes implant maker sees 71% sales jump as year-long glucose monitor grows - Stock Titan
Will Senseonics Holdings Inc. stock maintain momentum in 2025Weekly Risk Report & Real-Time Volume Trigger Notifications - Улправда
Will Senseonics Holdings Inc. stock maintain growth storyDividend Hike & Advanced Swing Trade Entry Alerts - ulpravda.ru
Is Senseonics Holdings Inc. stock trading at a premium valuationQuarterly Profit Report & AI Based Trade Execution Alerts - Улправда
Market Leaders: What sentiment indicators say about Senseonics Holdings Inc stockJuly 2025 Closing Moves & Safe Investment Capital Preservation Plans - Bộ Nội Vụ
SENS Stock Up as Eversense 365 Enters AID Market With twiist System - TradingView — Track All Markets
Is Senseonics Holdings (NASDAQ:SENS) Weighed On By Its Debt Load? - 富途牛牛
SENS Shares Surge After First Commercial Patients Use AID-Integrated Continuous Glucose Monitor System - Stocktwits
Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist™ Automated Insulin Delivery (AID) System - The Manila Times
How Senseonics Holdings Inc. stock performs in interest rate cyclesWeekly Investment Recap & Weekly Momentum Picks - Улправда
SENS: Senseonics Launches Product Integration with Sequel MedTec - GuruFocus
twiist becomes first AID system compatible with Eversense 365 CGM By Investing.com - Investing.com South Africa
twiist becomes first AID system compatible with Eversense 365 CGM - Investing.com
Dow Theory LettersSenseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist™ Automated Insulin Delivery (AID) System - FinancialContent
How Senseonics Holdings Inc. stock reacts to bond yieldsJuly 2025 Fed Impact & Verified Technical Trade Signals - ulpravda.ru
Why Senseonics Holdings Inc. stock is rated strong buyTrade Risk Report & AI Enhanced Execution Alerts - ulpravda.ru
Senseonics Holdings Inc Stock (SENS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):